[Anti-Tuberculous therapy with rifampicin and ethambutol during pregnancy (author's transl)].
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D012293:Rifampin
Antituberkulotische Therapie mit Ethambutol und Rifampicin in der Schwangerschaft